• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS SAMPLE PREP ASSISTANT II; STATION, PIPPETTING DILUTING CLINICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS SAMPLE PREP ASSISTANT II; STATION, PIPPETTING DILUTING CLINICAL Back to Search Results
Catalog Number 337170
Device Problem Contamination (1120)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/22/2020
Event Type  malfunction  
Manufacturer Narrative
Medical device expiration date: na.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that while using bd facs sample prep assistant ii carryover of samples occurred.There was no reported patient impact.The following information was provided by the initial reporter: it was reported that the spa fails carryover test.Customer problem: spa fails carryover test.Steps taken with customer/troubleshooting: no troubleshooting performed.Next steps (if necessary): create case / wo and dispatch direct to fse.Are you using this product for clinical diagnostic test? yes.Were erroneous results reported and used to treat a patient? no.Was there any injury or potential injury? no.Leak (if yes explain)? no.Software version? unknown.Resolution achieved (y/n)? unknown.Follow up required (y/n)? unknown.List of parts shipped (include foc): unknown.Rma required (y/n)? unknown.Is this a clinical or a research client? what instrument was used to perform the test? canto ii.Are the maintenance records up to date on the instrument? yes.How was the issue discovered? were erroneous results reported? cap survey.What type of specimen was it? bone marrow, peripheral blood? unknown.Was this a clinical specimen? yes.What testing was being performed? was this a standard leukemia/lymphoma panel? were there add-on tubes performed? unknown.Was the testing repeated or were the results confirmed? repeated.What was the diagnosis of the specimen tested prior to the specimen in question, and what was the cell count of the relevant cell population? unknown.What was the exact amount of carryover? how was this determined? plots.Are the dot plots from the analysis available for review? yes they are available.
 
Event Description
It was reported that while using bd facs sample prep assistant ii carryover of samples occurred.There was no reported patient impact.The following information was provided by the initial reporter: it was reported that the spa fails carryover test.Customer problem: spa fails carryover test steps taken with customer/troubleshooting: no troubleshooting performed next steps (if necessary): create case / wo and dispatch direct to fse are you using this product for clinical diagnostic test? yes were erroneous results reported and used to treat a patient? no was there any injury or potential injury? no leak (if yes explain)? no software version? unknown resolution achieved (y/n)? unknown follow up required (y/n)? unknown list of parts shipped (include foc): unknown rma required (y/n)? unknown is this a clinical or a research client? what instrument was used to perform the test? canto ii are the maintenance records up to date on the instrument? yes how was the issue discovered? were erroneous results reported? cap survey what type of specimen was it? bone marrow, peripheral blood? unknown was this a clinical specimen? yes what testing was being performed? was this a standard leukemia/lymphoma panel? were there add-on tubes performed? unknown was the testing repeated or were the results confirmed? repeated what was the diagnosis of the specimen tested prior to the specimen in question, and what was the cell count of the relevant cell population? unknown what was the exact amount of carryover? how was this determined? plots are the dot plots from the analysis available for review? yes they are available.
 
Manufacturer Narrative
After further review mfr#2916837-2020-00245 is no longer reportable.This device is for research use only and is not being used for diagnostic testing or patient treatment and is therefore not subject to mdr reporting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS SAMPLE PREP ASSISTANT II
Type of Device
STATION, PIPPETTING DILUTING CLINICAL
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
MDR Report Key10829459
MDR Text Key215960423
Report Number2916837-2020-00245
Device Sequence Number1
Product Code JQW
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 06/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number337170
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/22/2020
Initial Date FDA Received11/12/2020
Supplement Dates Manufacturer Received06/16/2021
Supplement Dates FDA Received06/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-